WallStreetZenWallStreetZen

NASDAQ: INSM
Insmed Inc Earnings & Revenue

INSM past revenue growth

How has INSM's revenue growth performed historically?
Company
24.39%
Industry
144.63%
Market
17.55%
INSM's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
INSM's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
INSM's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

INSM earnings and revenue history

Current Revenue
$305.2M
Current Earnings
-$749.6M
Current Profit Margin
-245.6%

INSM Return on Equity

Current Company
N/A
Current Industry
-63.5%
Current Market
188%

Be the first to know when INSM announces earnings.

INSM Return on Assets

Current Company
-53.4%
Current Industry
2.9%
INSM is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

INSM Return on Capital Employed

Current Company
-60.25%
Current Industry
19.5%
INSM's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

INSM vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
INSM$305.21M-$645.53M-$749.57M+98.78%N/A
RARE$434.25M-$582.46M-$606.64M+53.18%N/A
MDGL$0.00-$360.39M-$373.63MN/AN/A
IMVT$0.00-$242.72M-$243.45MN/AN/A
AXSM$270.60M-$223.54M-$239.24M+440.80%N/A

INSM earnings dates

Next earnings date
May 9, 2024

Insmed Earnings & Revenue FAQ

What were INSM's earnings last quarter?

On Invalid Date, Insmed (NASDAQ: INSM) reported Q4 2023 earnings per share (EPS) of -$1.28, up 4.07% year over year. Total Insmed earnings for the quarter were -$186.06 million. In the same quarter last year, Insmed's earnings per share (EPS) was -$1.23.

If you're new to stock investing, here's how to buy Insmed stock.

What was INSM's earnings growth in the past year?

As of Q2 2024, Insmed's earnings has grown year over year. Insmed's earnings in the past year totalled -$749.57 million.

What is INSM's earnings date?

Insmed's earnings date is Invalid Date. Add INSM to your watchlist to be reminded of INSM's next earnings announcement.

What was INSM's revenue last quarter?

On Invalid Date, Insmed (NASDAQ: INSM) reported Q4 2023 revenue of $83.69 million up 41.13% year over year. In the same quarter last year, Insmed's revenue was $59.30 million.

What was INSM's revenue growth in the past year?

As of Q2 2024, Insmed's revenue has grown 24.39% year over year. This is 120.24 percentage points lower than the US Biotechnology industry revenue growth rate of 144.63%. Insmed's revenue in the past year totalled $305.21 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.